Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Stress and Fatigue: Managing diabetes and potential medication side effects can be stressful and tiring, which are known triggers for eye twitching
To understand how these medications work, we have to look at the digestive system
Semaglutide is a GLP-1 receptor agonist that works by reducing appetite and helping you feel full faster
Investor Takeaway For investors seeking exposure to the GLP-1 boom in India, the key is to identify companies with proven capabilities in: Peptide synthesis Sterile injectable manufacturing Global regulatory compliance CDMO services with US/EU clients Recommended Monitoring: R&D updates and capacity expansions Any tie-ups with global GLP-1 players Clinical trial progress for biosimilar versions Regulatory approvals (USFDA, EMA) Export data to key markets (USA, Canada, China) Conclusion The weight loss drug boom is changing global healthcare and creating a huge business opportunity for Indian pharma companies
10.1016/j.phrs.2024.107401 22 FrasJ
DAscanio AM, Mullally JA, Frishman WH
US$ 24.99
US$ 25.73
US$ 25.94
